Specifically, SNP in PNPLA3, TM6SF2, MBOAT7 have repeatedly been shown to increase the susceptibility for and promote poor outcomes in NAFLD and ALD, while the indel in HSD17B13 assessed in our study was protective in previous analyses. This evidence concerns the gene HSD17B13 and metabolic dysfunction-associated steatotic liver disease.